{"id":5565,"date":"2014-07-01T07:48:00","date_gmt":"2014-07-01T07:48:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5565"},"modified":"2021-07-12T07:49:48","modified_gmt":"2021-07-12T07:49:48","slug":"granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/","title":{"rendered":"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease."},"content":{"rendered":"
\n

Chiara De Cassan<\/a> 1<\/a><\/sup>, Edoardo Savarino<\/a> 1<\/a><\/sup>, Piero Marson<\/a> 1<\/a><\/sup>, Tiziana Tison<\/a> 1<\/a><\/sup>, Giorgia Hatem<\/a> 1<\/a><\/sup>, Giacomo Carlo Sturniolo<\/a> 1<\/a><\/sup>, Renata D’Inc\u00e0<\/a> 1<\/a><\/sup> , World J Gastroenterol. 2014 Dec 7;20(45):17155-62.<\/p>\n<\/div>\n\n

\n

Patients with mild UC benefit from GMA more than patients with moderate to severe disease in the short-term period. GMA should be considered a valid therapeutic option in cases of contraindications to immunosuppressants, corticosteroids and\/or biologics.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/25493030\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4258586\/pdf\/WJG-20-17155.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Chiara De Cassan 1, Edoardo Savarino 1, Piero Marson 1, Tiziana Tison 1, Giorgia Hatem 1, Giacomo Carlo Sturniolo 1, Renata D’Inc\u00e0 1 , World J Gastroenterol. 2014 Dec 7;20(45):17155-62. Patients with mild UC benefit from GMA more than patients with moderate to severe disease in the short-term period. GMA should be considered a valid therapeutic option in cases of contraindications to immunosuppressants, corticosteroids and\/or biologics. https:\/\/pubmed.ncbi.nlm.nih.gov\/25493030\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4258586\/pdf\/WJG-20-17155.pdf<\/p>\n","protected":false},"template":"","scientific_tags":[105,312,374,107,375,376,306],"class_list":["post-5565","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-granulocyte","scientific_tags-immunology","scientific_tags-inflammatory-bowel-disease","scientific_tags-monocyte","scientific_tags-severity","scientific_tags-therapy","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"\nGranulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Chiara De Cassan 1, Edoardo Savarino 1, Piero Marson 1, Tiziana Tison 1, Giorgia Hatem 1, Giacomo Carlo Sturniolo 1, Renata D’Inc\u00e0 1 , World J Gastroenterol. 2014 Dec 7;20(45):17155-62. Patients with mild UC benefit from GMA more than patients with moderate to severe disease in the short-term period. GMA should be considered a valid therapeutic option in cases of contraindications to immunosuppressants, corticosteroids and\/or biologics. https:\/\/pubmed.ncbi.nlm.nih.gov\/25493030\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4258586\/pdf\/WJG-20-17155.pdf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:49:48+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/\",\"name\":\"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2014-07-01T07:48:00+00:00\",\"dateModified\":\"2021-07-12T07:49:48+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/","og_locale":"es_ES","og_type":"article","og_title":"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte","og_description":"Chiara De Cassan 1, Edoardo Savarino 1, Piero Marson 1, Tiziana Tison 1, Giorgia Hatem 1, Giacomo Carlo Sturniolo 1, Renata D’Inc\u00e0 1 , World J Gastroenterol. 2014 Dec 7;20(45):17155-62. Patients with mild UC benefit from GMA more than patients with moderate to severe disease in the short-term period. GMA should be considered a valid therapeutic option in cases of contraindications to immunosuppressants, corticosteroids and\/or biologics. https:\/\/pubmed.ncbi.nlm.nih.gov\/25493030\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4258586\/pdf\/WJG-20-17155.pdf","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:49:48+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/","name":"Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2014-07-01T07:48:00+00:00","dateModified":"2021-07-12T07:49:48+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulo-monocyto-apheresis-is-more-effective-in-mild-ulcerative-colitis-than-in-moderate-to-severe-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5565"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}